Business
DECN Secures Exclusive Distributor Agreement With a German Based Company for the Distribution of Genviro! Covid-19 :10 Saliva Testing Kits and Meters in 18 EU Countries, Norway and the UK
DECN Secures Exclusive Distributor Agreement With a German Based Company for the Distribution of Genviro! Covid-19 :10 Saliva Testing Kits and Meters in 18 EU Countries, Norway and the UK.
About this update from Decision Diagnostics Corp
[{"type":"text","content":"WITH THIS DEAL THE TOTAL NUMBER OF COUNTRIES COVERED BY DECN INTERNATIONAL AGREEMENTS NOW APPROACHES 50 WITH MORE ANTICIPATEDLOS ANGELES, CA / ACCESSWIRE / December 10, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co, a leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters through its subsidiary Pharma Tech Solutions, Inc., today announced it has signed an exclusive distribution agreement for its Genviro! testing product with a Deusseldorf, Germany-based distribution company currently doing business in 20 European countries.This new agreement covers sales to be made in various European territories, including the UK and Norway and nations in the European Union, including Germany, Austria, Switzerland, Ireland, France, Spain, Italy, Denmark, Sweden, Finland, Portugal, Belgium, Netherlands, Poland, Luxemburg, Hungary, Slovakia and the Czech Republic. The agreement's initial four (4) year term can be extended by the parties for one or more successive one (1) year renewal periods or such longer period as agreed to by them. This distributor will be responsible for the required EU filings and obtaining a CE mark. This announcement follows last week's announcement of a similar distribution-dealer agreement covering the Russian Federation countries and the Ukraine."We continue to follow our international strategy and we are seeing the benefits. This most recent announcement of an exclusive agreement with an EU distributor covering a significant portion of Europe reflects further interest in Genviro's! :10 testing ability to detect Covid-19 and follows what we've already experienced with similar agreements covering India, other countries in Asia, the Russian Federation, the Caribbean and Central America as well as Nigeria, Ivory Coast and Lebanon," said CEO Keith Berman. "While finalizing our US FDA testing has taken somewhat longer than we would have anticipated, we continue to have conversations with distributors around the world who have shown substantial interest in Genviro! and we will continue to cultivate international activity."NOT YET AVAILABLE IN THE UNITED STATES OR PUERTO RICOAs previously reported, according to an August study from BBC Research and reported in a Korea Times news article, the global ...